Treatment of melasma using a novel 1,927-nm fractional thulium fiber laser: a pilot study.
Identifieur interne : 000518 ( Ncbi/Merge ); précédent : 000517; suivant : 000519Treatment of melasma using a novel 1,927-nm fractional thulium fiber laser: a pilot study.
Auteurs : Kristel D. Polder [États-Unis] ; Suzanne BruceSource :
- Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.] [ 1524-4725 ] ; 2012.
Descripteurs français
- KwdFr :
- MESH :
- effets indésirables : Thérapie laser.
- Adulte, Adulte d'âge moyen, Femelle, Humains, Lasers à solide, Mâle, Mélanose.
English descriptors
- KwdEn :
- MESH :
- adverse effects : Laser Therapy.
- therapy : Melanosis.
- Adult, Female, Humans, Lasers, Solid-State, Male, Middle Aged.
Abstract
A 1,927-nm wavelength was recently added to the 1,550-nm erbium-doped fiber laser. This wavelength possesses a higher absorption coefficient for water than the 1,550-nm, conferring greater ability to target epidermal processes such as dyschromia.
DOI: 10.1111/j.1524-4725.2011.02178.x
PubMed: 22093448
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 000406
- to stream PubMed, to step Curation: 000406
- to stream PubMed, to step Checkpoint: 000406
Links to Exploration step
pubmed:22093448Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Treatment of melasma using a novel 1,927-nm fractional thulium fiber laser: a pilot study.</title><author><name sortKey="Polder, Kristel D" sort="Polder, Kristel D" uniqKey="Polder K" first="Kristel D" last="Polder">Kristel D. Polder</name><affiliation wicri:level="2"><nlm:affiliation>Department of Dermatology, University of Texas at Houston, Houston, Texas, USA. kristelpolder@hotmail.com</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Dermatology, University of Texas at Houston, Houston, Texas</wicri:regionArea><placeName><region type="state">Texas</region></placeName></affiliation></author><author><name sortKey="Bruce, Suzanne" sort="Bruce, Suzanne" uniqKey="Bruce S" first="Suzanne" last="Bruce">Suzanne Bruce</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2012">2012</date><idno type="doi">10.1111/j.1524-4725.2011.02178.x</idno><idno type="RBID">pubmed:22093448</idno><idno type="pmid">22093448</idno><idno type="wicri:Area/PubMed/Corpus">000406</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000406</idno><idno type="wicri:Area/PubMed/Curation">000406</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000406</idno><idno type="wicri:Area/PubMed/Checkpoint">000406</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000406</idno><idno type="wicri:Area/Ncbi/Merge">000518</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Treatment of melasma using a novel 1,927-nm fractional thulium fiber laser: a pilot study.</title><author><name sortKey="Polder, Kristel D" sort="Polder, Kristel D" uniqKey="Polder K" first="Kristel D" last="Polder">Kristel D. Polder</name><affiliation wicri:level="2"><nlm:affiliation>Department of Dermatology, University of Texas at Houston, Houston, Texas, USA. kristelpolder@hotmail.com</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Dermatology, University of Texas at Houston, Houston, Texas</wicri:regionArea><placeName><region type="state">Texas</region></placeName></affiliation></author><author><name sortKey="Bruce, Suzanne" sort="Bruce, Suzanne" uniqKey="Bruce S" first="Suzanne" last="Bruce">Suzanne Bruce</name></author></analytic><series><title level="j">Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]</title><idno type="eISSN">1524-4725</idno><imprint><date when="2012" type="published">2012</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term><term>Female</term><term>Humans</term><term>Laser Therapy (adverse effects)</term><term>Lasers, Solid-State</term><term>Male</term><term>Melanosis (therapy)</term><term>Middle Aged</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adulte</term><term>Adulte d'âge moyen</term><term>Femelle</term><term>Humains</term><term>Lasers à solide</term><term>Mâle</term><term>Mélanose ()</term><term>Thérapie laser (effets indésirables)</term></keywords><keywords scheme="MESH" qualifier="adverse effects" xml:lang="en"><term>Laser Therapy</term></keywords><keywords scheme="MESH" qualifier="effets indésirables" xml:lang="fr"><term>Thérapie laser</term></keywords><keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Melanosis</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adult</term><term>Female</term><term>Humans</term><term>Lasers, Solid-State</term><term>Male</term><term>Middle Aged</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adulte</term><term>Adulte d'âge moyen</term><term>Femelle</term><term>Humains</term><term>Lasers à solide</term><term>Mâle</term><term>Mélanose</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">A 1,927-nm wavelength was recently added to the 1,550-nm erbium-doped fiber laser. This wavelength possesses a higher absorption coefficient for water than the 1,550-nm, conferring greater ability to target epidermal processes such as dyschromia.</div></front></TEI><pubmed><MedlineCitation Owner="NLM" Status="MEDLINE"><PMID Version="1">22093448</PMID><DateCreated><Year>2012</Year><Month>02</Month><Day>07</Day></DateCreated><DateCompleted><Year>2012</Year><Month>03</Month><Day>19</Day></DateCompleted><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1524-4725</ISSN><JournalIssue CitedMedium="Internet"><Volume>38</Volume><Issue>2</Issue><PubDate><Year>2012</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]</Title><ISOAbbreviation>Dermatol Surg</ISOAbbreviation></Journal><ArticleTitle>Treatment of melasma using a novel 1,927-nm fractional thulium fiber laser: a pilot study.</ArticleTitle><Pagination><MedlinePgn>199-206</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/j.1524-4725.2011.02178.x</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">A 1,927-nm wavelength was recently added to the 1,550-nm erbium-doped fiber laser. This wavelength possesses a higher absorption coefficient for water than the 1,550-nm, conferring greater ability to target epidermal processes such as dyschromia.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To evaluate the efficacy and safety of a novel 1,927-nm fractional thulium fiber laser in the treatment of melasma.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Fourteen patients underwent three to four laser treatments (at 4-week intervals) at pulse energies of 10 to 20 mJ and total densities of 252 to 784 microscopic treatment zones per cm(2) (6-8 passes) using a 1,927-nm thulium fiber laser. Three blinded assessors and the patients evaluated clinical improvement of treatment areas at 1-, 3-, and 6-month follow-ups. Side effects were assessed, and pain was scored using a visual analog scale (0-10).</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A statistically significant 51% reduction in MASI score was observed at 1-month post 3 to 4 laser treatments. A 33% (p = .06) and 34% (p = .07) reduction in Melasma Area and Severity Index score was observed at the 3- and 6-month follow-up visits, respectively. Skin responses observed after treatment were moderate erythema and mild edema. No scarring or postinflammatory hyper- or hypopigmentation was observed.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The 1,927-nm fractional thulium fiber laser is a safe, effective treatment for melasma.</AbstractText><CopyrightInformation>© 2011 by the American Society for Dermatologic Surgery, Inc. Published by Wiley Periodicals, Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Polder</LastName><ForeName>Kristel D</ForeName><Initials>KD</Initials><AffiliationInfo><Affiliation>Department of Dermatology, University of Texas at Houston, Houston, Texas, USA. kristelpolder@hotmail.com</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bruce</LastName><ForeName>Suzanne</ForeName><Initials>S</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2011</Year><Month>10</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Dermatol Surg</MedlineTA><NlmUniqueID>9504371</NlmUniqueID><ISSNLinking>1076-0512</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="Y" UI="D053685">Laser Therapy</DescriptorName><QualifierName MajorTopicYN="N" UI="Q000009">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="Y" UI="D053844">Lasers, Solid-State</DescriptorName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D008548">Melanosis</DescriptorName><QualifierName MajorTopicYN="Y" UI="Q000628">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="aheadofprint"><Year>2011</Year><Month>10</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2011</Year><Month>11</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2011</Year><Month>11</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2012</Year><Month>3</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="doi">10.1111/j.1524-4725.2011.02178.x</ArticleId><ArticleId IdType="pubmed">22093448</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>États-Unis</li></country><region><li>Texas</li></region></list><tree><noCountry><name sortKey="Bruce, Suzanne" sort="Bruce, Suzanne" uniqKey="Bruce S" first="Suzanne" last="Bruce">Suzanne Bruce</name></noCountry><country name="États-Unis"><region name="Texas"><name sortKey="Polder, Kristel D" sort="Polder, Kristel D" uniqKey="Polder K" first="Kristel D" last="Polder">Kristel D. Polder</name></region></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Terre/explor/ThuliumV1/Data/Ncbi/Merge
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000518 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd -nk 000518 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Terre
|area= ThuliumV1
|flux= Ncbi
|étape= Merge
|type= RBID
|clé= pubmed:22093448
|texte= Treatment of melasma using a novel 1,927-nm fractional thulium fiber laser: a pilot study.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/RBID.i -Sk "pubmed:22093448" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd \
| NlmPubMed2Wicri -a ThuliumV1
| This area was generated with Dilib version V0.6.21. |  |